NS
Novonesis (Novozymes) B
NSISBC.XD · DXE
432.00 kr +0.98% (+4.20 kr)
1M +2.64%
Market Cap 119.3B kr
P/E Ratio 26.79x
Div. Yield -
ROE 5.52%
Bulios Fair Price
314.62 kr
27.2% downside
Trenutna cena
432 kr
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NSISBC.XD trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
46 /100
Fair P/B 1.46x
P/S 3.81x
P/E 26.79x
Growth
73 /100
Growing Book val. growth 91.72%
FCF growth 19.34%
EPS growth 9.91%
Profitability
100 /100
Strong FCF margin 19.97%
Op. margin 19.48%
Gross margin 54.34%
Quality
36 /100
Average Asset turnover 0.25x
ROA 3.61%
ROIC 4.14%
Debt
89 /100
Low Net debt/EBITDA 1.95x
Int. coverage 57.08x
Debt/Equity 0.29x
Stability
88 /100
Stable Profitable years 4
EPS volatility 22.49%
Beta 0.93x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NSISBC.XD
Online
Sector
Basic Materials
Industry
Chemicals - Specialty
CEO
Ester Baiget
Employees
10,582
Headquarters
Kongens Lyngby